According to Matinas BioPharma's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -C$31.91 Million a decrease over its 2022 earnings that were of -C$29.21 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.